61 – 70 of 76
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience.
(
- Contribution to journal › Article
- 2003
-
Mark
Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB
(
- Contribution to journal › Article
-
Mark
Interactions between the leukaemia-associated ETO homologues of nuclear repressor proteins.
(
- Contribution to journal › Article
-
Mark
Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant
(
- Contribution to journal › Article
-
Mark
Early and intermediate stage Hodgkin's lymphoma - report from the Swedish National Care Programme.
(
- Contribution to journal › Article
- 2002
-
Mark
Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation
(
- Contribution to journal › Article
-
Mark
A population-based study of the outcome for patients with first relapse of Hodgkin's lymphoma
(
- Contribution to journal › Article
- 2001
-
Mark
Identification of numerical and structural chromosome aberrations in 15 high hyperdiploid childhood acute lymphoblastic leukemias using spectral karyotyping
(
- Contribution to journal › Article
- 2000
-
Mark
Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukemias
(
- Contribution to journal › Article
- 1999
-
Mark
A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender
(
- Contribution to journal › Article